Literature DB >> 10632361

Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.

P P McKenzie1, S M Guichard, D S Middlemas, R A Ashmun, M K Danks, L C Harris.   

Abstract

p53 is a tumor suppressor protein important in the regulation of apoptosis. Because p53 functions as a transcription factor, cellular responses depend upon activity of p53 localized in the nucleus. Cytoplasmic sequestration of p53 has been proposed as a mechanism by which the function of this protein can be suppressed, particularly in tumor types such as neuroblastoma in which the frequency of mutations of p53 is low. Data presented here demonstrate that nuclear p53 protein is expressed in a panel of neuroblastoma cell lines, and after exposure to DNA damage, transcriptionally active p53 expression can be induced. After exposure to both equitoxic IC80 and 10-Gy doses of ionizing radiation, both p53 and p21 were induced, but G1 cell cycle arrest was attenuated. To investigate whether the DNA damage signaling pathway was incapable of inducing sufficient p53 in these cells, we expressed additional wild-type p53 after adenoviral vector transduction. This exogenous p53 expression also resulted in p21 induction but was unable to enhance the G1 arrest, suggesting that the pathway downstream from p53 is nonfunctional. Although p53-mediated G1 arrest is attenuated in neuroblastoma cells, the ability of p53 to induce apoptosis appears functional, consistent with its chemosensitive phenotype. This work demonstrates that p53 is expressed in the nucleus of neuroblastoma cells and can mediate induction of p21. However, this cell type appears to have an attenuated ability to mediate a DNA damage-induced G1 cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10632361

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  21 in total

1.  Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.

Authors:  Pritha Paul; Lauren A Gillory; JungHee Kang; Jingbo Qiao; Dai H Chung
Journal:  Surgery       Date:  2010-10-29       Impact factor: 3.982

2.  MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.

Authors:  E A Afanasyeva; P Mestdagh; C Kumps; J Vandesompele; V Ehemann; J Theissen; M Fischer; M Zapatka; B Brors; L Savelyeva; V Sagulenko; F Speleman; M Schwab; F Westermann
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

3.  p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells.

Authors:  D A Tweddle; A J Malcolm; M Cole; A D Pearson; J Lunec
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

4.  Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis.

Authors:  C S Coleman; J P Rocetes; D J Park; C J Wallick; B J Warn-Cramer; K Michel; R Dudler; A S Bachmann
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

5.  Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model.

Authors:  Thilo S Lange; Yongping Zou; Rakesh K Singh; Kyu K Kim; Katrin Kristjansdottir; Giselle L S Sholler; Laurent Brard
Journal:  Chem Biol Drug Des       Date:  2010-05-11       Impact factor: 2.817

6.  Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.

Authors:  Min-Kyeong Kim; Bu-Nam Jeon; Dong-In Koh; Kyung-Sup Kim; So-Yoon Park; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

7.  CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.

Authors:  Sina Gogolin; Volker Ehemann; Gabriele Becker; Lena M Brueckner; Daniel Dreidax; Steffen Bannert; Ingo Nolte; Larissa Savelyeva; Emma Bell; Frank Westermann
Journal:  Cell Cycle       Date:  2013-03-05       Impact factor: 4.534

8.  P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells.

Authors:  Yifu Sun; Peng Xia; Haipeng Zhang; Biao Liu; Ying Shi
Journal:  Am J Cancer Res       Date:  2015-12-15       Impact factor: 6.166

9.  Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.

Authors:  M Majumder; A K Ghosh; R Steele; R Ray; R B Ray
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer.

Authors:  J Li; E K O Ng; Y P Ng; C Y P Wong; J Yu; H Jin; V Y Y Cheng; M Y Y Go; P K F Cheung; M P A Ebert; J Tong; K F To; F K L Chan; J J Y Sung; N Y Ip; W K Leung
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.